-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Verona Pharma plc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
- Verona Pharma plc Operating Income (Loss) for the quarter ending September 30, 2024 was -$40.7M, a 149% decline year-over-year.
- Verona Pharma plc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$155M, a 145% decline year-over-year.
- Verona Pharma plc annual Operating Income (Loss) for 2023 was -$67.6M, a 10.8% increase from 2022.
- Verona Pharma plc annual Operating Income (Loss) for 2022 was -$75.8M, a 3.32% decline from 2021.
- Verona Pharma plc annual Operating Income (Loss) for 2021 was -$73.3M, a 1.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)